Maria Collantes

Pamplona, NC 31008, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Evaluation of nanoencapsulated bevacizumab combined with paclitaxel in a colorectal cancer xenograft model.

Evaluation of nanoencapsulated bevacizumab combined with paclitaxel in a colorectal cancer xenograft model.

Journal: Drug delivery and translational research

Published: July 26, 2025

Oral lipoteichoic and lipoic acids improve insulin resistance and body composition in porphyria mice on a high-carbohydrate diet.

Oral lipoteichoic and lipoic acids improve insulin resistance and body composition in porphyria mice on a high-carbohydrate diet.

Journal: Journal of physiology and biochemistry

Published: May 22, 2025

Engineered Mycoplasma pneumoniae targeting dual-species bacterial biofilms: a novel strategy against infections.

Engineered Mycoplasma pneumoniae targeting dual-species bacterial biofilms: a novel strategy against infections.

Journal: NPJ biofilms and microbiomes

Published: April 01, 2025

Phosphatidylserine as a tumor target for CAR-T cell therapy.

Phosphatidylserine as a tumor target for CAR-T cell therapy.

Journal: Journal for immunotherapy of cancer

Published: February 03, 2025

Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions.

Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions.

Journal: Nature communications

Published: December 18, 2024

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease.

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease.

Journal: Brain, behavior, and immunity

Published: December 16, 2024

4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.

4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models.

Journal: Journal for immunotherapy of cancer

Published: November 01, 2024

Enhancing bevacizumab efficacy in a colorectal tumor mice model using dextran-coated albumin nanoparticles.

Enhancing bevacizumab efficacy in a colorectal tumor mice model using dextran-coated albumin nanoparticles.

Journal: Drug delivery and translational research

Published: October 18, 2024

Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates.

Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates.

Journal: Gut

Published: April 09, 2024

A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer.

A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer.

Journal: Frontiers in immunology

Published: August 04, 2023

Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria.

Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria.

Journal: International journal of molecular sciences

Published: June 29, 2023

Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin.

Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin.

Journal: International journal of pharmaceutics

Published: May 05, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026